Sohrab Ahmadivand

Dr. Sohrab Ahmadivand

Tierärztliche Fakultät, Ludwig-Maximilians-Universität München, Munich, Bavaria, Germany
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 March 2025 in Cells
Verified
Journal Article
Open access
PDF file
Sohrab AhmadivandSohrab Ahmadivand
Sohrab Ahmadivand
RFRobert Fux
Robert Fux
Dusan PalicDusan Palic
Dusan Palic
T follicular helper (Tfh) cells are a specialized subset of CD4+ T lymphocytes that are essential for the development of long-lasting humoral immunity. Tfh cells facilitate B lymphocyte maturation, promote germinal center formation, and drive high-affinity antibody production. Our current knowledge of Tfh interactions with the humoral immune system effectors suggests that they have a critical role in supporting the immune response against viral infections. This review discusses the mechanisms through which Tfh cells influence anti-viral immunity, highlighting their interactions with B cells and their impact on antibody quality and quantity. We explore the role of Tfh cells in viral infections and examine how vaccine design can be improved to enhance Tfh cell responses. Innovative vaccine platforms, such as mRNA vaccines and self-assembling protein nanoplatforms (SAPNs), are promising strategies to enhance Tfh cell activation. Their integration and synergistic combination could further enhance immunity and Tfh responses (SAPN-RNA vaccines). In summary, we provide a comprehensive overview of the current insights into Tfh cells’ role during viral infections, emphasizing their potential as strategic targets for innovative vaccine development.

29 January 2024 in Frontiers in Immunology
Verified
Journal Article
Open access
Sohrab AhmadivandSohrab Ahmadivand
Sohrab Ahmadivand
ZKZeljka Krpetic
Zeljka Krpetic
MMMerce Márquez Martínez
Merce Márquez Martínez
MGMarlid Garcia-Ordoñez
Marlid Garcia-Ordoñez
NRNerea Roher
Nerea Roher
Dusan PalicDusan Palic
Dusan Palic
Self-assembling protein nanoparticles are used as a novel vaccine design platform to improve the stability and immunogenicity of safe subunit vaccines, while providing broader protection against viral infections. Infectious Hematopoietic Necrosis virus (IHNV) is the causative agent of the WOAH-listed IHN diseases for which there are currently no therapeutic treatments and no globally available commercial vaccine. In this study, by genetically fusing the virus glycoprotein to the H. pylori ferritin as a scaffold, we constructed a self-assembling IHNV nanovaccine (FerritVac). Despite the introduction of an exogenous fragment, the FerritVac NPs show excellent stability same as Ferritin NPs under different storage, pH, and temperature conditions, mimicking the harsh gastrointestinal condition of the virus main host (trout). MTT viability assays showed no cytotoxicity of FerritVac or Ferritin NPs in zebrafish cell culture (ZFL cells) incubated with different doses of up to 100 µg/mL for 14 hours. FerritVac NPs also upregulated expression of innate antiviral immunity, IHNV, and other fish rhabdovirus infection gene markers (mx, vig1, ifit5, and isg-15) in the macrophage cells of the host. In this study, we demonstrate the development of a soluble recombinant glycoprotein of IHNV in the E. coli system using the ferritin self-assembling nanoplatform, as a biocompatible, stable, and effective foundation to rescue and produce soluble protein and enable oral administration and antiviral induction for development of a complete IHNV vaccine. This self-assembling protein nanocages as novel vaccine approach offers significant commercial potential for non-mammalian and enveloped viruses.

27 September 2024 in Vaccines
Verified
Journal Article
Open access
PDF file
Sohrab AhmadivandSohrab Ahmadivand
Sohrab Ahmadivand
RFRobert Fux
Robert Fux
Dusan PalicDusan Palic
Dusan Palic
Viral infections in animals continue to pose a significant challenge, affecting livestock health, welfare, and food safety, and, in the case of zoonotic viruses, threatening global public health. The control of viral diseases currently relies on conventional approaches such as inactivated or attenuated vaccines produced via platforms with inherent limitations. Self-assembling ferritin nanocages represent a novel vaccine platform that has been utilized for several viruses, some of which are currently undergoing human clinical trials. Experimental evidence also supports the potential of this platform for developing commercial vaccines for veterinary viruses. In addition to improved stability and immunogenicity, ferritin-based vaccines are safe and DIVA-compatible, and can be rapidly deployed in response to emerging epidemics or pandemics. This review discusses the structural and functional properties of ferritin proteins, followed by an overview of the design and production of ferritin-based vaccines, the mechanisms of immune responses, and their applications in developing vaccines against animal and zoonotic viruses.

1 December 2020 in Molecular and Cellular Probes
Verified
Journal Article
Closed access
HRHooman Rahmati-Holasoo
Hooman Rahmati-Holasoo
Sohrab AhmadivandSohrab Ahmadivand
Sohrab Ahmadivand
SSSara Shokrpoor
Sara Shokrpoor
MEMansour El-Matbouli
Mansour El-Matbouli

28 May 2025 in Viruses
Verified
Journal Article
Open access
PDF file
Sohrab AhmadivandSohrab Ahmadivand
Sohrab Ahmadivand
ASAyanna Carla Phillips Savage
Ayanna Carla Phillips Savage
Dusan PalicDusan Palic
Dusan Palic
Emerging RNA viruses pose a critical threat to aquatic animals, leading to significant ecological and economic consequences. Their high mutation rates and genetic adaptability drive rapid evolution, cross-species transmission, and expanding host ranges, complicating disease management. In aquaculture, RNA viruses are responsible for major outbreaks in fish, while DNA viruses predominate in crustaceans. Marine mammals are increasingly affected by morbilliviruses and highly pathogenic avian influenza (HPAI) H5N1, which has caused widespread mortality events in pinniped and cetacean populations, raising concerns about zoonotic spillover. The absence of effective antiviral treatments and the complexity of vaccine development highlight the urgent need for enhanced biosecurity measures. Furthermore, novel vaccine approaches, such as self-assembling protein nanocage platforms, offer promising solutions for RNA virus mitigation. This review provides a comprehensive analysis of the emergence and significance of RNA viruses in aquatic animals over the last two decades, with a particular focus on biosecurity and vaccine development.

5 July 2022 in Aquaculture International
Verified
Journal Article
Closed access
PDF file
HRHooman Rahmati-Holasoo
Hooman Rahmati-Holasoo
Sohrab AhmadivandSohrab Ahmadivand
Sohrab Ahmadivand
Amin MarandiAmin Marandi
Amin Marandi
SSSara Shokrpoor
Sara Shokrpoor
Dusan PalicDusan Palic
Dusan Palic
AJAdib Jahangard
Adib Jahangard